Omalizumab biosimilar is under clinical development by Mabpharm and currently in Phase III for Chronic Urticaria Or Hives. According ...

Allergies affect millions of people in Singapore, impacting daily life and overall well-being. Identifying allergens through ...

INR:9518. my available time slots Novartis' next-generation IgE antibody therapy receives FDA breakthrough therapy designation China's first COVID-19 reco ...

INR:6225. powerful football team names Innovent Biologics' PD-1 third indication marketing application accepted! Second-line treatment of squamous NS ...